Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years.
Roberto Luigi CazzatoPierre De MariniPierre AulogeLoic LeclercThibault TricardVeronique LinderMarion JostNitin RamamurthyHervé LangJulien GarnonAfshin GangiPublished in: European radiology (2020)
• MRI-guided biopsy of radiologically indeterminate solid renal masses (RM) appears safe, with a low rate of minor self-limiting hemorrhagic complications. • Diagnostic accuracy and primary/secondary diagnostic yield are high and appear similar to reported estimates for US- and CT-guided RM biopsy. • MRI guidance may be particularly useful for RM with poor conspicuity on US and CT, for relatively inaccessible tumors (e.g., tumors requiring double-oblique steep-angled approaches), and for young patients or those with renal failure.
Keyphrases
- contrast enhanced
- fine needle aspiration
- ultrasound guided
- magnetic resonance imaging
- computed tomography
- magnetic resonance
- diffusion weighted imaging
- end stage renal disease
- dual energy
- newly diagnosed
- chronic kidney disease
- prognostic factors
- patient reported outcomes
- peritoneal dialysis
- positron emission tomography
- patient reported